Hong Kong PE Firm Zendex Bio Strategy Invests In Chinese Pharma JV

Login to View

Hong Kong-based private equity firm, Zendex Bio Strategy has partnered with two respiratory product companies to set up Kinnovata Pharmaceutical Company in Tianjin, hoping to take advantage of China’s increasing demand for asthma-related medical products.

The two partners are

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription